Retatrutide and Body Composition: What Trial Data Shows About Lean Mass and Gluteal Changes
Short answer: The retatrutide phase 2 trial (338 adults, NEJM 2023) reported mean weight loss of up to 24.2 percent at 48 weeks but did not publish regional body composition data, so the gluteal ...
Read guide →